On this date, the implanting clinician removed the trial leads and advised the patient to follow up at a local hospital to get an ultrasound to rule out a blood clot.The patient was sent home from the hospital after the ultrasound and was told no clots were present.At a follow-up appointment with the implanting clinician on september 8, 2020, the implanting clinician identified that the patient had developed cellulitis and prescribed oral antibiotic treatment (type, dosage, duration unknown).The clinical representative confirmed that the implant procedure was performed in a sterile environment with sterile field handling protocols, sterile barriers of all products used were intact before the implant, and the procedure was completed following the product instructions for use.Based on this information, the infection was confirmed/replicated.There is no evidence that the product did not meet specifications, and the stimulator is used to treat pain.The cause of the infection is unknown/no problem found.
|